Related Experiment Videos

Cataractogenic effects in rats following chronic administration of SDZ ICT 322, a selective 5-HT3 antagonist

U W Längle1, A Wolf, M E Kammüller

  • 1Sandoz Pharma Ltd., Toxicology, Basel, Switzerland.

Related Concept Videos